Generative models for protein sequence modeling: recent advances and future directions.

Mehrsa Mardikoraem, Zirui Wang, Nathaniel Pascual, Daniel Woldring

Journal: Briefings in bioinformatics 2024;24(6):bbad358

PMID: 37864295

Abstract

The widespread adoption of high-throughput omics technologies has exponentially increased the amount of protein sequence data involved in many salient disease pathways and their respective therapeutics and diagnostics. Despite the availability of large-scale sequence data, the lack of experimental fitness annotations underpins the need for self-supervised and unsupervised machine learning (ML) methods. These techniques leverage the meaningful features encoded in abundant unlabeled sequences to accomplish complex protein engineering tasks. Proficiency in the rapidly evolving fields of protein engineering and generative AI is required to realize the full potential of ML models as a tool for protein fitness landscape navigation. Here, we support this work by (i) providing an overview of the architecture and mathematical details of the most successful ML models applicable to sequence data (e.g. variational autoencoders, autoregressive models, generative adversarial neural networks, and diffusion models), (ii) guiding how to effectively implement these models on protein sequence data to predict fitness or generate high-fitness sequences and (iii) highlighting several successful studies that implement these techniques in protein engineering (from paratope regions and subcellular localization prediction to high-fitness sequences and protein design rules generation). By providing a comprehensive survey of model details, novel architecture developments, comparisons of model applications, and current challenges, this study intends to provide structured guidance and robust framework for delivering a prospective outlook in the ML-driven protein engineering field.

© The Author(s) 2023. Published by Oxford University Press.

Address: Michigan State University (MSU)'s Department of Chemical Engineering and Materials Science.; Regeneron Pharmaceuticals, Inc. Having received his B.S. in Chemical Engineering from MSU, he is currently pursuing a M.S. in Computer Science from Syracuse University.; B.S. in Chemical Engineering from MSU.; MSU's Department of Chemical Engineering and Materials Science and a member of MSU's Institute for Quantitative Health Sciences and Engineering.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.